Video

Dr. Lilenbaum on the Challenges of Integrating Telehealth Services in Lung Cancer

Rogerio C. Lilenbaum, MD, discusses the challenges of integrating telehealth services in lung cancer.

Rogerio C. Lilenbaum, MD, director, Banner MD Anderson Cancer Center, discusses the challenges of integrating telehealth services in lung cancer.

In the era of the coronavirus disease 2019 (COVID-19), telehealth has become a key tool in the continuum of patient care. However, despite best efforts to streamline virtual care before the COVID-19 pandemic, challenges remain in utilizing telehealth to its full potential, says Lilenbaum.

Although many of these hurdles have been overcome over the course of the pandemic, it is not fully understood what role telemedicine will play in cancer care after the pandemic, concludes Lilenbaum.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
BDTX-1535 – A MasterKey EGFR Inhibitor Targeting Classical, Non-Classical, and the C797S Resistance Mutation To Address The Evolved Landscape Of EGFR Mutant NSCLC
Video 14 - "Key Takeaways in HER2-Mutated NSCLC"
Video 13 - "Treatment Considerations in HER2-Mutated NSCLC"
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Sumanta Kumar Pal, MD, FASCO,
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer